What is the address of Dr. Heleen Cypers, Reumatologie?

The registered office of Dr. Heleen Cypers, Reumatologie is located at Verloren Kost 65, 3680 Maaseik.

Is Dr. Heleen Cypers, Reumatologie still active?

Yes. According to the CBE (30 September 2026) Dr. Heleen Cypers, Reumatologie is active, legal situation “Normale toestand”, started on 22 December 2022.

Is Dr. Heleen Cypers, Reumatologie registered on Peppol?

Yes, Dr. Heleen Cypers, Reumatologie is registered on the Peppol network with ID 0208:0795234803.

What is the enterprise number of Dr. Heleen Cypers, Reumatologie?

The enterprise number of Dr. Heleen Cypers, Reumatologie is BE0795234803.

When was Dr. Heleen Cypers, Reumatologie founded?

Dr. Heleen Cypers, Reumatologie was founded on 22 December 2022.

Who are the directors of Dr. Heleen Cypers, Reumatologie?

According to the 2025 annual accounts, the directors of Dr. Heleen Cypers, Reumatologie are: Heleen Cuypers.

Is Dr. Heleen Cypers, Reumatologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 December 2022; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Heleen Cypers, Reumatologie make in 2025?

Dr. Heleen Cypers, Reumatologie posted a profit after taxes of € 41,961 in financial year 2025.

What is the revenue of Dr. Heleen Cypers, Reumatologie?

As a small company, Dr. Heleen Cypers, Reumatologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 58,165.

Dr. Heleen Cypers, Reumatologie (Private Limited)

Dossier Dr. Heleen Cypers, Reumatologie, printed on 30 September 2026 from databakkes.be/en/0795234803/dr-heleen-cypers-reumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Heleen Cypers, Reumatologie from Maaseik, company number BE0795234803, closed financial year 2025 with a result of € 41,961 after tax. For that financial year Dr. Heleen Cypers, Reumatologie recorded a gross margin of € 58,165 and equity of € 94,692. Compared with financial year 2024, the result moved from € 23,277 to € 41,961. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 19, 2026.

What it is worth Growing

€ 94,692

▲ 80% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 41,961

▲ 80% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 43,592

▲ 158% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 88,692.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,633

▲ 1% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,003

▲ 59% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 34,764 Gross margin 2023: € 34,764 First fiscal year in the series	€ 35,526 Gross margin 2024: € 35,526 ▲ 2% vs 2023 (€ 34,764) Favourable step	€ 58,165 Gross margin 2025: € 58,165 ▲ 64% vs 2024 (€ 35,526) Favourable step	▲ 64%
Profit after taxes	€ 23,454 Profit after taxes 2023: € 23,454 First fiscal year in the series	€ 23,277 Profit after taxes 2024: € 23,277 ▼ 1% vs 2023 (€ 23,454) Unfavourable step	€ 41,961 Profit after taxes 2025: € 41,961 ▲ 80% vs 2024 (€ 23,277) Favourable step	▲ 80%
Equity	€ 29,454 Equity 2023: € 29,454 First fiscal year in the series	€ 52,731 Equity 2024: € 52,731 ▲ 79% vs 2023 (€ 29,454) Favourable step	€ 94,692 Equity 2025: € 94,692 ▲ 80% vs 2024 (€ 52,731) Favourable step	▲ 80%
Total debts	€ 15,684 Total debts 2023: € 15,684 First fiscal year in the series	€ 10,726 Total debts 2024: € 10,726 ▼ 32% vs 2023 (€ 15,684) Favourable step	€ 6,157 Total debts 2025: € 6,157 ▼ 43% vs 2024 (€ 10,726) Favourable step	▼ 43%
Cash	€ 15,210 Cash 2023: € 15,210 First fiscal year in the series	€ 16,908 Cash 2024: € 16,908 ▲ 11% vs 2023 (€ 15,210) Favourable step	€ 43,592 Cash 2025: € 43,592 ▲ 158% vs 2024 (€ 16,908) Favourable step	▲ 158%
Retained profit	€ 23,454 Retained profit 2023: € 23,454 First fiscal year in the series	€ 46,731 Retained profit 2024: € 46,731 ▲ 99% vs 2023 (€ 23,454) Favourable step	€ 88,692 Retained profit 2025: € 88,692 ▲ 90% vs 2024 (€ 46,731) Favourable step	▲ 90%
Balance sheet total	€ 45,138 Balance sheet total 2023: € 45,138 First fiscal year in the series	€ 63,457 Balance sheet total 2024: € 63,457 ▲ 41% vs 2023 (€ 45,138) Unchanged	€ 100,849 Balance sheet total 2025: € 100,849 ▲ 59% vs 2024 (€ 63,457) Unchanged	▲ 59%

Key figures of Dr. Heleen Cypers, Reumatologie, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Heleen Cypers, Reumatologie?

What happened at Dr. Heleen Cypers, Reumatologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 19, 2026 New annual accounts for financial year 2025: profit of € 41,961 (▲ 80% vs 2024). Source: NBB ↗
Dec 22, 2022 New establishment in Maaseik. KBO
2022 Heleen Cuypers became a director. NBB
Dec 22, 2022 Start of the company according to the CBE. KBO

In short

From € 23,454 profit in 2023 to € 41,961 profit in 2025.

Paid € 23,637 in corporate taxes since 2023.

Best year ever: 2025, with € 41,961 profit.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Heleen Cypers, Reumatologie? We notify you, reason included.

Follow Dr. Heleen Cypers, Reumatologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Heleen Cuypers

Dr. Heleen Cypers, Reumatologie

Behind Dr. Heleen Cypers, Reumatologie is Heleen Cuypers.

See the full network in the app

Directors

According to the 2025 annual accounts

Heleen Cuypers

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Verloren Kost 65

3680 Maaseik

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0795.234.803
VAT number: BE 0795.234.803
Registered office: Verloren Kost 65, 3680 Maaseik
Names & denominations: Dr. Heleen Cypers, Reumatologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 December 2022
Peppol: Active · Active since 28 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗